BRCA1 and BRCA2 mutations in a South American population

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• High-risk families for breast and ovarian cancer often carry germline mutations in BRCA1 and BRCA2 genes.
• Understanding the spectrum of these mutations in specific populations is crucial for genetic testing and counseling.

Purpose of the Study:

• To screen Chilean high-risk breast and/or ovarian cancer families for germline mutations in BRCA1 and BRCA2.
• To identify prevalent and novel mutations within the Chilean population.

Main Methods:

• Conformation-sensitive gel electrophoresis was used to screen coding sequences and exon-intron boundaries of BRCA1 and BRCA2.
• Identified mutations were confirmed using direct sequencing.

Main Results:

• Germline mutations were identified in 10.9% of families for BRCA1 and 4.7% for BRCA2.
• Six distinct pathogenic mutations were found in BRCA1, including two novel mutations. Three distinct pathogenic mutations were found in BRCA2, including one novel mutation.
• Nine variants of unknown significance (five in BRCA1, four in BRCA2) were also identified.

Conclusions:

• The Chilean population exhibits a heterogeneous spectrum of prevalent BRCA mutations.
• Comprehensive screening of the entire BRCA1 and BRCA2 coding regions is necessary for molecular genetic testing in Chilean high-risk patients.
• These findings provide a basis for improved genetic counseling and preventive strategies in Chile.